Register to receive a free U.S. Dialysis Devices Market Report synopsis and brochure. Utilizing an artificial kidney device to streamline dialysis for at home patients, HemoCare is an alternative to clinic-based treatment that may prove to be more effective and convenient. In a study involving 70 patients, CVS Health will begin testing their product before
iData ResearchClinic Based Dialysis Market May Be Disrupted by New HemoCare Device
Register to receive a free US Dialysis Market Report Suite report synopsis and brochure On July 3rd 2019, Advent Access announced the CE Mark certificate for its well-known and accredited av-Guardian™ vascular access system. This designation indicates av-Guardian™’s conformity with health, safety, and environmental protection standards set by the European Union for a device to be distributed
iData ResearchAdvent Access Receives CE Mark Certificate for Pioneering av-Guardian™ Vascular Access System
Register to receive a free US Market Report Suite for Dialysis Device and Concentrates report synopsis and brochure Fresenius Medical Care, a major player in the kidney care medical industry, announced on March 14, 2019 that the FDA has granted approval for software to help fluid management during hemodialysis. The software will be designed to work with newer
iData ResearchFresenius Medical Care Receives FDA Clearance for Fluid Management During Hemodialysis
Register to receive a free US Market Report Suite for Dialysis Device and Concentrates report synopsis and brochure AWAK Technologies recently announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to their AWAK Peritoneal Dialysis (PD) device, a portable and wearable PD system fitted with AWAK’s proven and patented sorbent technology. AWAK
iData ResearchAWAK Technologies’ Wearable Dialysis Device Designated Breakthough Device by FDA
Register to receive a free US Market Report Suite for Dialysis Device and Concentrates report synopsis and brochure Antitrust attorneys working with third parties told CTFN that a divestiture of NxStage’s bloodline tubing unit is being discussed as a condition in closing its $2 billion acquisition by Fresenius. “NxStage is DaVita’s longstanding and preferred bloodline tubing vendor,”
iData ResearchManageable Divestiture Likely in the Works for NxStage/Fresenius Merger
Register to receive a free US Market Report Suite for Dialysis Device and Concentrates report synopsis and brochure Proteon Therapeutics, Inc., a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular diseases, today announced that it has completed enrollment in PATENCY-2, the second Phase 3 clinical trial of investigational vonapanitase,
iData ResearchProteon Therapeutics Completes Enrollment in PATENCY-2, Phase 3 Clinical Trial of Investigational Vonapanitase
The system won initial clearance in 2005 and added clearance for home nocturnal hemodialysis in 2014, the Lawrence, Mass.-based company said, but has always required a care partner be present during hemodialysis.
iData ResearchNxStage Medical Wins Expanded FDA Nod for System One Home Hemodialysis System
Peritoneal dialysis is a home-based dialysis therapy that offers patients a more flexible and physiologically smoother dialysis option. Unlike hemodialysis, peritoneal dialysis uses a patient’s peritoneal membrane to remove toxins and excess fluid from the patient.
iData ResearchPuraCath Medical Presents New Peritoneal Dialysis Research During Dialysis Conference